DermTech, Inc.

NasdaqCM:DMTK 株式レポート

時価総額:US$11.1m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

DermTech 過去の業績

過去 基準チェック /06

主要情報

-36.7%

収益成長率

-5.8%

EPS成長率

Biotechs 業界の成長17.0%
収益成長率33.0%
株主資本利益率-224.1%
ネット・マージン-572.2%
前回の決算情報31 Mar 2024

最近の業績更新

Recent updates

DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 44%

May 21
DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 44%

We're A Little Worried About DermTech's (NASDAQ:DMTK) Cash Burn Rate

Mar 02
We're A Little Worried About DermTech's (NASDAQ:DMTK) Cash Burn Rate

Investors Don't See Light At End Of DermTech, Inc.'s (NASDAQ:DMTK) Tunnel And Push Stock Down 28%

Mar 02
Investors Don't See Light At End Of DermTech, Inc.'s (NASDAQ:DMTK) Tunnel And Push Stock Down 28%

Revenues Working Against DermTech, Inc.'s (NASDAQ:DMTK) Share Price

Dec 28
Revenues Working Against DermTech, Inc.'s (NASDAQ:DMTK) Share Price

Companies Like DermTech (NASDAQ:DMTK) Could Be Quite Risky

Sep 18
Companies Like DermTech (NASDAQ:DMTK) Could Be Quite Risky

Can DermTech (NASDAQ:DMTK) Afford To Invest In Growth?

Jun 14
Can DermTech (NASDAQ:DMTK) Afford To Invest In Growth?

Need To Know: The Consensus Just Cut Its DermTech, Inc. (NASDAQ:DMTK) Estimates For 2023

May 10
Need To Know: The Consensus Just Cut Its DermTech, Inc. (NASDAQ:DMTK) Estimates For 2023

DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 37%

May 06
DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 37%

We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate

Jan 16
We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate

Analyst Forecasts Just Became More Bearish On DermTech, Inc. (NASDAQ:DMTK)

Nov 08
Analyst Forecasts Just Became More Bearish On DermTech, Inc. (NASDAQ:DMTK)

Will DermTech (NASDAQ:DMTK) Spend Its Cash Wisely?

Oct 11
Will DermTech (NASDAQ:DMTK) Spend Its Cash Wisely?

DermTech grants stock options

Oct 11

Diving Into DermTech

Sep 01

Earnings Release: Here's Why Analysts Cut Their DermTech, Inc. (NASDAQ:DMTK) Price Target To US$23.80

Aug 10
Earnings Release: Here's Why Analysts Cut Their DermTech, Inc. (NASDAQ:DMTK) Price Target To US$23.80

DermTech: Approaching An All Or Nothing Moment

Jun 13

We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate

Jun 04
We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate

DermTech - Taking A Second Look At The Growth Thesis

Mar 31

DermTech: Adoption Headwinds And Earnings Misses

Dec 23

Companies Like DermTech (NASDAQ:DMTK) Are In A Position To Invest In Growth

Dec 02
Companies Like DermTech (NASDAQ:DMTK) Are In A Position To Invest In Growth

DermTech - Game Changer, Set To Become The Leader In Skin Diagnostics

Sep 15

We Think DermTech (NASDAQ:DMTK) Can Afford To Drive Business Growth

Sep 03
We Think DermTech (NASDAQ:DMTK) Can Afford To Drive Business Growth

DermTech: Transforming The Melanoma Diagnosis Landscape

Aug 31

DermTech: Becoming More Appealing, Despite Nosebleed Valuation

Aug 09

DermTech appoints former Myriad Genetics executive as new chief medical officer

Jun 16

We're Not Very Worried About DermTech's (NASDAQ:DMTK) Cash Burn Rate

Jun 05
We're Not Very Worried About DermTech's (NASDAQ:DMTK) Cash Burn Rate

収支内訳

DermTech の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

NasdaqCM:DMTK 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
31 Mar 2416-907414
31 Dec 2315-1018315
30 Sep 2314-1109017
30 Jun 2314-1209719
31 Mar 2314-1189822
31 Dec 2215-1179524
30 Sep 2215-1159225
30 Jun 2214-1068424
31 Mar 2213-937520
31 Dec 2112-786216
30 Sep 2111-635012
30 Jun 219-52419
31 Mar 217-45357
31 Dec 206-36305
30 Sep 205-31274
30 Jun 205-27243
31 Mar 204-21193
31 Dec 193-20152
30 Sep 192-18122
30 Jun 192-1482
31 Mar 193-1372
31 Dec 182-1062
31 Dec 172-862
30 Jun 140-623
31 Mar 140-622

利益率の向上: DMTKは現在利益が出ていません。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: DMTKは利益が出ておらず、過去 5 年間で損失は年間36.7%の割合で増加しています。


株主資本利益率


総資産利益率


使用総資本利益率


過去の好業績企業の発掘